Viewing Study NCT01746095


Ignite Creation Date: 2025-12-24 @ 2:09 PM
Ignite Modification Date: 2026-04-16 @ 4:07 AM
Study NCT ID: NCT01746095
Status: COMPLETED
Last Update Posted: 2020-01-13
First Post: 2012-12-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
Sponsor: Savara Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-03
Start Date Type: None
Primary Completion Date: 2014-11
Primary Completion Date Type: ACTUAL
Completion Date: 2014-11
Completion Date Type: ACTUAL
First Submit Date: 2012-12-06
First Submit QC Date: None
Study First Post Date: 2012-12-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-06-01
Results First Submit QC Date: None
Results First Post Date: 2020-01-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-12-23
Last Update Post Date: 2020-01-13
Last Update Post Date Type: ACTUAL